Updated on 2025/03/27

写真a

 
Matsuoka Yuko
 
Organization
University Hospital Assistant Professor
Title
Assistant Professor
Contact information
メールアドレス
External link

Degree

  • 工学博士 ( 2020.3   東海大学 )

Research Areas

  • Life Science / Immunology

Professional Memberships

Papers

  • Importance of particle size of oligomannose-coated liposomes for induction of Th1 immunity. Reviewed International journal

    Yuko Matsuoka, Emi Onohara, Naoya Kojima, Yasuhiro Kuroda

    International immunopharmacology   99   108068 - 108068   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Oligomannose-coated liposomes (OMLs) comprised of dipalmitoylphosphatidylcholine, cholesterol and Man3-DPPE at a molar ratio of 1:1:0.1 and particle diameters of about 1000 nm can induce liposome-encased antigen-specific strong Th1 immunity. In this study, we evaluated the effect of particle sizes of OMLs on induction of Th1 immune responses in mice. Spleen cells obtained from mice immunized with antigen-encapsulating OMLs with 1000- and 800-nm diameters secreted remarkably high levels of IFN-γ upon in vitro stimulation. In addition, sera of mice that received these OMLs had significantly higher titers of antigen-specific IgG2a than those of IgG1, which are commonly associated with Th1 responses. In contrast, treatment with antigen-encapsulating OMLs with 400- and 200-nm diameters failed to induce IFN-γ secretion from spleen cells, although these OMLs did elicit elevation of antigen-specific IgGs. In addition, the titers of serum antigen-specific IgG2a were the same as those of IgG1 in mice that received 400-nm OMLs. Resident peritoneal mononuclear phagocytes (MNPs) treated with OMLs of diameter ≥ 600 nm secreted IL-12, which is essential for induction of Th1 immune responses, while those treated with OMLs of ≤ 400 nm failed to produce this cytokine. However, 400-nm OMLs did induce enhanced expression of MHC class II and costimulatory molecules on MNPs, similarly to OMLs of ≥ 600 nm. Taken together, these results strongly indicate that OMLs of diameter ≥ 600 nm are required to induce Th1 immune responses against OML-encased antigens, although OMLs of diameter ≤ 400 nm can activate MNPs.

    DOI: 10.1016/j.intimp.2021.108068

    PubMed

    researchmap

  • In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose. Reviewed International journal

    Yuko Matsuoka, Yoko Kawauchi, Kiyotaka Kawauchi, Akari Takiyama, Shohei Kojima, Yasuhiro Kuroda, Naoya Kojima

    Glycoconjugate journal   36 ( 3 )   185 - 197   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In this study, we assessed the potential of liposomes coated with a neoglycolipid containing α1-3,α1-6-mannotriose residues (Man3-DPPE; Manα1-6(Manα1-3)Manitol-DPPE) for in vitro activation and maturation of human mononuclear phagocytes. In response to treatment with Man3-DPPE-coated liposomes (Man3-OMLs), PMA-stimulated human THP-1 cells showed enhanced expression of CD40, CD80 and HLA-DR and secreted significant levels of IL-12p40. Among various linkages of Man2-DPPE-coated liposomes, only liposomes coated with Manα1-6Manitol-DPPE (α1-6Man2-DPPE) induced these cellular responses similarly to Man3-OML treatment. Liposomes coated with Manα1-6(Manα1-3)Manα1-6(Manα1-3)Manitol-DPPE (Man5-DPPE) failed to activate the cells. These results suggest that an unsubstituted α1-6Man branch bound to a mannitol unit at the reducing end in Man3-DPPE is required for in vitro activation of human mononuclear phagocytes. Man3-OML-induced IL-12p40 production was not inhibited by BAY11-7082, an inhibitor of the MyD88-dependent signaling network, suggesting that TLRs are not involved in activation of human mononuclear phagocytes by Man3-OMLs. Stimulation of inflammatory monocytes or monocyte-derived dendritic cells (moDCs) with Man3-OMLs also induced enhanced expression of co-stimulatory molecules, HLA-DR, and CCR7, and IL-12p40 production from both types of cells. In response to Man3-OML treatment, moDCs but not inflammatory monocytes produced bioactive IL-12p70, which was enhanced by CD40 ligation. Thus, Man3-OMLs can activate naïve human mononuclear phagocytes and lead human moDCs to a fully matured status in vitro to elicit CTLs and a Th1 response without addition of inflammatory cytokines or TLR agonists.

    DOI: 10.1007/s10719-019-09870-6

    PubMed

    researchmap

  • In vitro uptake of oligomannose-coated liposomes leads to differentiation of inflammatory monocytes into mature antigen-presenting cells that can activate T cells. Reviewed International journal

    Yuko Matsuoka, Yoko Kawauchi, Yasuhiro Kuroda, Kiyotaka Kawauchi, Naoya Kojima

    International immunopharmacology   57   102 - 111   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Oligomannose-coated liposomes (OMLs), containing entrapped antigens, serve as effective antigen delivery vehicles and as a novel adjuvant to induce antigen-specific cellular immune responses. However, in vitro activation of antigen-presenting cells (APCs) by OMLs has not yet been demonstrated. In this paper, we found that OMLs can deliver the antigens and the stimulatory signals into inflammatory monocytes in vitro, leading to differentiation of the cells to mature APCs. When OMLs were co-cultured with peripheral blood mononuclear cells from C57BL/6 mice in the presence of mouse serum, OMLs were preferentially incorporated into both Ly6Chigh monocytes and Ly6Clow monocytes, which are referred to as murine inflammatory and resident monocytes, respectively. The expression of CD11c, CD80, CD86, CCR7, and MHC class II on the Ly6Chigh monocytes was significantly enhanced during the 24 h after OML uptake, whereas upregulation of these molecules on the Ly6Clow monocytes was limited. In addition, the antigenic peptide of OVA encased in OMLs was presented on MHC class I of only Ly6Chigh monocytes. Furthermore, OVA-encasing OML-ingesting monocytes can activate CD8+ T cells from OT-1 mice, suggesting that antigens encapsulated in OMLs were cross-presented in inflammatory monocytes. Adoptive transfer of the monocytes that engulf OVA-encasing OMLs led to induction of an antigen-specific Th1 immune response in mice. Taken together, mature APCs can be generated from inflammatory monocytes in peripheral blood by ex vivo treatment of the cells with OMLs without any additional stimuli.

    DOI: 10.1016/j.intimp.2018.02.013

    PubMed

    researchmap

  • Requirement of TLR4 signaling for the induction of a Th1 immune response elicited by oligomannose-coated liposomes. Reviewed International journal

    Yuko Matsuoka, Hideaki Takagi, Minami Yamatani, Yasuhiro Kuroda, Katsuaki Sato, Naoya Kojima

    Immunology letters   178   61 - 7   2016.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We have previously demonstrated that administration of oligomannose-coated liposomes (OMLs), in which an antigen is encased, induce antigen-specific Th1 immune responses and CTLs. In the present study, we showed that TLR4 signaling is required for the induction of specific immune responses following OML administration. In C3H/HeJ mice, which express a dysfunctional TLR4, the antigen-specific Th1 immune response could not be elicited following intraperitoneal administration of OVA-encased OMLs (OML/OVA). However, OML uptake by peritoneal cells, the subsequent production of IL-12 and the upregulation of co-stimulatory molecules and MHC class II on the cells in response to OML uptake occurred in C3H/HeJ mice to the same extent as in wild type C3H/HeN mice. In addition, peritoneal phagocytic cells from TLR4(-/-) mice that ingest OML/OVA can activate CD4(+) T cells from OT-II mice. On the other hand, the number of OML-ingesting peritoneal cells that migrated into mesenteric lymph nodes in C3H/HeJ mice was significantly less than that in C3H/HeN mice. Therefore, the chemotactic capability of OML-ingesting peritoneal phagocytes to the draining lymph nodes rather than the activation and maturation of the cells in response to OML uptake is impaired by lack of TLR4 signaling, and disorder of the Th1 immune response elicited by OMLs in mice, which lack TLR4 signaling, is due to the impairment of cell migration following OML uptake.

    DOI: 10.1016/j.imlet.2016.07.016

    PubMed

    researchmap

MISC

  • Oligomannose-coated liposomes: a novel antigen delivery vehicle to mononuclear phagocytes and an efficient platform for vaccines for induction of cellular immunity

    Yuko Matsuoka, Yasuhiro Kuroda, Naoya Kojima

    CYTOKINE   100   79 - 79   2017.12

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Web of Science

    researchmap

Research Projects

  • T細胞老化制御による抗腫瘍活性増強法の確立

    2022.4 - 2024.3

    日本学術振興会  科学研究費助成事業  若手研究

    松岡 祐子

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap

  • The enhancement of anti-tumor activity by removal of senescent T cells

    2020.9 - 2022.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    Matsuoka Yuko

      More details

    Grant amount:\2860000 ( Direct Cost: \2200000 、 Indirect Cost:\660000 )

    Chimeric antigen receptor T-cell therapy is the most remarkable cancer treatment. However, there are many problems that need to be solved. One of them is the T cell senescence. During in vivo transplantation, Senescent T cells interfere with sufficient anti-tumor activity.
    In this study, we attempted to establish a method to enhance the anti-tumor activity of removal senescent T cells by targeting Gfi1, which is involved in the survival of senescent T cells. However, suppression of Gfi1 expression tended to decrease antitumor activity. Therefore, removal of senescent T cells targeting Gfi1 did not enhance anti tumor activity.

    researchmap